CINECA IRIS Institutional Research Information System

FORNAI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.090
AS - Asia 7.371
EU - Europa 6.563
SA - Sud America 1.040
AF - Africa 386
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 7
Totale 30.487
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.664
IT - Italia 2.632
SG - Singapore 2.372
CN - Cina 1.997
HK - Hong Kong 1.133
BR - Brasile 865
SE - Svezia 837
VN - Vietnam 603
DE - Germania 595
BG - Bulgaria 431
GB - Regno Unito 389
FI - Finlandia 325
TR - Turchia 291
CA - Canada 290
FR - Francia 286
RU - Federazione Russa 269
AT - Austria 210
IN - India 206
JP - Giappone 172
UA - Ucraina 157
CI - Costa d'Avorio 148
KR - Corea 126
NL - Olanda 111
PL - Polonia 77
MX - Messico 76
CH - Svizzera 75
AR - Argentina 68
IQ - Iraq 64
PK - Pakistan 60
BD - Bangladesh 59
SN - Senegal 48
BE - Belgio 45
UZ - Uzbekistan 39
ZA - Sudafrica 39
NG - Nigeria 37
ID - Indonesia 32
SA - Arabia Saudita 28
IR - Iran 27
MA - Marocco 27
ES - Italia 26
VE - Venezuela 26
EC - Ecuador 25
PH - Filippine 24
AU - Australia 23
EG - Egitto 19
CO - Colombia 17
KE - Kenya 15
AZ - Azerbaigian 14
CZ - Repubblica Ceca 14
MY - Malesia 14
PY - Paraguay 14
AE - Emirati Arabi Uniti 13
LT - Lituania 13
TW - Taiwan 13
JO - Giordania 12
TN - Tunisia 12
DZ - Algeria 11
JM - Giamaica 11
CL - Cile 10
IE - Irlanda 10
NO - Norvegia 9
PT - Portogallo 9
IL - Israele 8
KZ - Kazakistan 8
LB - Libano 8
OM - Oman 8
PA - Panama 8
UY - Uruguay 8
AL - Albania 7
BJ - Benin 7
HN - Honduras 7
HU - Ungheria 6
KG - Kirghizistan 6
NZ - Nuova Zelanda 6
PS - Palestinian Territory 6
RO - Romania 6
TT - Trinidad e Tobago 6
ET - Etiopia 5
GR - Grecia 5
NP - Nepal 5
PE - Perù 5
CR - Costa Rica 4
DO - Repubblica Dominicana 4
GD - Grenada 4
GH - Ghana 4
LV - Lettonia 4
QA - Qatar 4
RS - Serbia 4
SV - El Salvador 4
AO - Angola 3
BS - Bahamas 3
BY - Bielorussia 3
CG - Congo 3
DK - Danimarca 3
EU - Europa 3
GE - Georgia 3
GT - Guatemala 3
NI - Nicaragua 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
Totale 30.454
Salva come PNG Salva come JPEG
Città #
Ashburn 1.547
Singapore 1.306
Woodbridge 1.125
Fairfield 1.106
Hong Kong 1.099
Dallas 965
Ann Arbor 959
San Jose 896
Houston 871
Chandler 821
Santa Clara 791
Milan 513
Seattle 439
Sofia 427
Wilmington 426
Shanghai 420
Beijing 407
Cambridge 387
Serra 382
New York 314
Boardman 258
Los Angeles 225
Ottawa 200
Princeton 184
Jacksonville 164
Lawrence 160
Council Bluffs 159
Pisa 156
Lauterbourg 152
Abidjan 148
Izmir 147
Vienna 146
Tokyo 144
Medford 139
Florence 135
Hefei 133
Helsinki 124
Munich 123
Ho Chi Minh City 120
Dong Ket 112
Rome 110
Nanjing 108
Des Moines 105
Seoul 104
Hanoi 103
London 101
Chicago 89
Istanbul 86
Buffalo 84
Frankfurt am Main 83
São Paulo 77
Bremen 75
Redondo Beach 74
Dearborn 62
Nanchang 56
Turku 54
Lucca 53
Dakar 48
Lancaster 46
Warsaw 46
Columbus 45
Lappeenranta 45
Ogden 43
Brussels 42
Falls Church 42
San Diego 41
Bern 40
The Dalles 40
Redwood City 37
Atlanta 35
Tashkent 35
Nuremberg 34
Lagos 33
Chennai 32
Orem 30
Pune 30
Washington 30
Jüchen 29
Naples 29
Zurich 29
Marseille 28
Toronto 28
Montignoso 27
Phoenix 27
Hebei 26
Montreal 26
Boulder 25
Tianjin 25
Kunming 24
Rio de Janeiro 24
Amsterdam 23
Brooklyn 23
Guangzhou 23
Livorno 23
Belo Horizonte 22
Fuzhou 22
Baghdad 20
Kent 20
Manchester 20
Norwalk 20
Totale 21.091
Salva come PNG Salva come JPEG
Nome #
Derivati isoindolici come attivatori di AMPK 539
Preparation of isoindoline derivatives for use as AMPK activators 346
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 305
Protective effects of Saccharomyces boulardii CNCM I-745 Against Nonsteroidal anti-inflammatory drug-induced intestinal injury 291
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 272
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 272
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 267
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 251
Derivati benzofuranici come attivatori di AMPK 250
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 234
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 230
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 228
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 226
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 226
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 216
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 215
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 214
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 211
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 211
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 210
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 208
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 204
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability 203
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 203
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 200
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 200
Preclinical development of fa5, a novel amp-activated protein kinase (Ampk) activator as an innovative drug for the management of bowel inflammation 199
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 198
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 198
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 197
Dietary Supplement, Containing the Dry Extract of Curcumin, Emblica and Cassia, Counteracts Intestinal Inflammation and Enteric Dysmotility Associated with Obesity 196
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 196
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 195
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 194
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 193
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 193
NLRP3 at the crossroads between immune/inflammatory responses and enteric neuroplastic remodelling in a mouse model of diet-induced obesity 193
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 192
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 191
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 190
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 189
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 189
Efficay and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: a review 187
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 186
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 186
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 185
Role of A2a adenosine in the regulation of colonic motility in normal human colon 184
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 184
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 184
Effects of pantoprazole on ulcer healing delay associated with NSAID treatment 183
Preparation of benzofuran derivatives for use as AMPK activators 182
Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury 181
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 181
Expression pattern of COX isoforms in experimental models of enteric and airway inflammation 180
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 180
Genetic polymorphisms of thiopurine S-methyltransferase in a cohort of patients with systemic autoimmune diseases 180
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 180
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 179
Interplay between colonic inflammation and tachykininergic pathways in the onset of colonic dysmotility in a mouse model of diet-induced obesity 179
Evaluation of cytokine levels as putative biomarkers to predict the pharmacological response to biologic therapy in inflammatory bowel diseases 179
Donepezil improves vascular function in a mouse model of Alzheimer's disease 178
Mechanisms underlying the non-anticoagulant effects of apixaban and dabigatran on the integrity of intestinal mucosa: a comparative pre-clinical study. 177
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 177
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 176
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 176
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 175
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 175
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson’s disease before brain pathology 175
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 174
Reduced modulating actions of adenosine pathways on enteric neuromuscular activity in experimental colitis 174
Allopurinol adherence among patients with gout: an Italian general practice database study 172
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease 171
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 171
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 171
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 171
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 170
Differential role of A1 and A2a purinergic receptors in the control of colonic neurumuscular function in the presence of experimental colitis 169
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 169
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 169
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 167
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 167
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 167
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 166
Managing Obesity and Related Comorbidities: A Potential Pharmacological Target in the Adenosine System? 165
The intestinal barrier in disorders of the central nervous system 164
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 162
Transient acute liver failure complicating transurethral resection syndrome 162
Enteric Glia and Brain Astroglia: Complex Communication in Health and Disease along the Gut-Brain Axis 161
Adenosine and inflammation: what's new on the horizon? 161
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 160
Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship 160
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 159
Mild hypothyroidism anticipates and accelerates age-related endothelial dysfunction in rat mesenteric small arteries: role of inducibile NO synthase 157
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 157
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 157
NSAID activated gene (NAG-1) plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer repair 156
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 156
Risankizumab for the treatment of moderate to severe psoriasis 156
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 155
Adenosine signaling in the tumor microenvironment 154
Totale 19.474
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.965
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.965
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021311 0 0 0 0 0 0 0 0 0 0 0 311
2021/20221.993 36 97 62 114 377 282 79 118 109 79 138 502
2022/20232.877 314 380 206 287 292 362 32 234 500 49 189 32
2023/20242.504 243 251 298 196 380 405 59 108 104 93 123 244
2024/20256.578 76 245 106 404 574 722 602 304 694 865 687 1.299
2025/20267.992 533 852 1.033 634 837 651 1.267 409 537 796 283 160
Totale 31.200